Live · 18 Sep 2026 SPX 7,637.76 +1.14% NDX 29,446.98 +1.73% VIX 15.44 -12.82% GOLD 4,405.80 +0.14% CL 101.02 -0.87% BTC 77,436.19 +0.00%
NAS100 29,447 +1.73% S&P 7,638 +1.14% GOLD $4,406 +0.14% BTC $77,436 VIX 15.44 −12.82% live tape · as of 11:00 UTC
The Screen · Industrials · Specialty Industrial Machinery

Crane Co logoCrane Co

CR · the NYSE · USD · Market cap $11.4B · 9,000 employees

Crane Company, together with its subsidiaries, engages in the manufacture and sale of engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally.

PASS · Titan Ethical · score 70.0
197.77 USD

At the last full screen
2026-09-17

Screened 2026-09-17 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markdown label.

Crane Co holds its Markdown at $197.77. Consolidating, no directional conviction, held for 13 days.

As held on the ledger · 2026-09-17
PhaseMarkdown · caution
Quantitative stateConsolidating, no directional conviction, held for 13 days
Price at the screen$197.77
Valuation34.58 trailing · 25.26 forward price to earnings
Values screenPASS · score 70.0
Beta1.08
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 31.56% Below 33% Interest-bearing debt is just 31.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 22.45% Below 49% Money owed to the company is 22.5% of assets, under the 49% limit. Pass
Revenue purity 0.49% Below 5% Only 0.5% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

What the Numbers Say It Is Worth

The Fair Value Range

172.80Conservative198.78Base case228.60Growth case 197.77Price

Fair value range in USD, drawn from the 2026-09-17 screen. The gold marker is the market price at the same screen. A 0.5% margin of safety to the base estimate.

The Street's Range
192.00Street low 241.00Street average 253.00Street high 197.77Price

Third-party analyst targets: 10 covering, consensus Strong Buy. The average target sits +22% from the screen price.

Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections
$267$166$65TODAY3y agoPROJECTIONStreet high$253.00 +28%Street avg$241.00 +22%Our fair value$198.78 +1%Conservative$172.80 -13%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Crane pays up for steady industrial kit

Picture a factory floor where every valve and actuator must survive brutal conditions. Crane builds those components across aerospace and industrial markets, posting 25% revenue growth and a 13% profit margin while earning a 17% return on equity. The narrow moat and clean ethical screen are real, yet none of that offsets the gap between the current price and our fair value.

At 28.5 times forward earnings the shares sit 13% above fair value with an opportunity rating of none. Strong analyst targets around 225 do not change the arithmetic. Paying a premium multiple for a narrow-moat industrial name leaves little room for the ordinary setbacks that hit this sector.

Cyclical exposure means earnings can peak just when multiples compress. Investors chasing the growth number risk anchoring to high-water marks that later prove fleeting. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E25.3xfairly priced for its growth rate
Trailing P/E34.6xa premium valuation
EPS, trailing5.72
EPS, forward7.83
Revenue growth+25.6%strong top-line growth
Profit margin13.0%thin but positive margins
Return on equity16.5%a solid return on shareholder capital
FCF yield3.18%
Dividend yield49.00%
Debt to equity0.51moderate, manageable leverage
Current ratio2.80comfortably covers its short-term bills
Beta1.08moves a little more than the market
Short interest, float0.02%
52-week range159.58 - 230.50
MoatNARROW
Market cap$11.4B
Employees9,000

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-08-25 Distribution · changed $219.04 +0.7% Entry 5

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220.

2026-07-25 Markup $217.49 +5.3% Entry 4

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220.

2026-07-18 Markup $206.57 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220.

2026-07-03 Markup $206.57 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markup $206.57 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in CR's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming CR
DatePoliticianPartyTypeAmount
9 Sept2024 Tracey Mann Republican sell 1K–15K
9 Sept2024 Tracey Mann Republican sell 1K–15K
9 Sept2024 Tracey Mann Republican sell 1K–15K
9 Jun2026 Tony Wied Republican sell 100K–250K
8 Jul2026 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $182.31 +8.4% $0.26 $1,085 +8.5%
2 months $188.20 +5.0% $0.26 $1,051 +5.1%
3 months $179.11 +10.3% $0.26 $1,105 +10.5%
6 months $192.42 +2.7% $0.51 $1,030 +3.0%
1 year $185.72 +6.4% $0.97 $1,069 +6.9%
2 years $141.01 +40.2% $1.84 $1,415 +41.5%
3 years $79.32 +149.2% $2.61 $2,524 +152.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CR does next, these words stay.

Crane Co · CR · Markdown · $197.77
Recorded 2026-09-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.